1 active not recruiting, 1 recruiting, 1 withdrawn. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Episodic Ataxia, Type 2: new trials by email Literature Review of Episodic Ataxia, Type 2 trials Research Report on Episodic Ataxia, Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pivotal Study of N-acetyl-L-leucine for CACNA1A N-Acetyl-L-Leucine, Placebo - CACNA1A, Spinocerebellar Ataxia Type 6 | Phase 3 | Active not recruiting | IntraBio Inc | 60 | 2026-08-17 | 2026-11-03 |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford Rare Disorders, Undiagnosed Disorders | Recruiting | Sanford Health | 20000 | 2010-07-01 | 2026-10-28 | |
| 4-Aminopyridine in Episodic Ataxia Type 2 4-Aminopyridine, Placebo - Episodic Ataxia Type 2 | Phase 2 | Withdrawn | University of California, Los Angeles | 2020-11-16 |
Spinocerebellar Ataxias (2) · 3-Methylglutaconic Aciduria, Type V (1) · Achalasia Addisonianism Alacrimia syndrome (1) · Acrodysostosis (1) · Activated PI3K-delta Syndrome (1) · Addison Disease (1) · Alagille Syndrome (1) · Alstrom Syndrome (1) · Amnesia, Transient Global (1) · Aniridia (1) · Aniridia and Absent Patella (1) · Aniridia, Partial, with Unilateral Renal Agenesis and Psychomotor Retardation (1) · Ataxia (1) · Ataxia Neuropathy Spectrum (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Cerebellar Ataxia (2) · Cerebellar Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dyskinesias (2) · Genetic Diseases, Inborn (2) · Heredodegenerative Disorders, Nervous System (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Neurologic Manifestations (2) · Spinal Cord Diseases (2) · Abnormalities, Multiple (1) · Adrenal Gland Diseases (1) · Adrenal Insufficiency (1)
4-Aminopyridine (1) · acetylleucine (1)
IntraBio Inc (1) · Sanford Health (1) · University of California, Los Angeles (1)
United States (3) · Austria (1) · Germany (1) · Greece (1) · Italy (1) · Switzerland (1) · United Kingdom (1)
2025 (1)